The precision genetic medicine biotech also said it hopes to grow its manufacturing footprint and launch another program into the clinic next year.
Encoded Therapeutics has tacked on $275 million in new capital, closing a Series F round led by GV and an undisclosed healthcare investor.
The precision …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A gene therapy designed by Encoded Therapeutics reduced seizures by 76% in children with Dravet syndrome, a severe…
Cartesian’s $150M financing; Editas Medicine’s money moves
Epicrispr has raised a Series C round after sharing promising early data for EPI-321, a potential new way to treat…
Lyora Therapeutics launches with $2.5M in pre-seed funding to revive stalled eye gene therapy programs from Editas and Biogen,…
Anxiously awaiting an FDA decision this fall, Beren Therapeutics has added $300 million in new capital to help launch its rare…
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a
